MedPath

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

Not Applicable
Completed
Conditions
Premature Luteinization
Registration Number
NCT00447850
Lead Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Brief Summary

Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Oocyte donors
  • Age between 18-35 years old
  • BMI 18-29
  • NORMOGONADOTROPHICS
  • PROGESTERONE ≥ 1.2 ng/ml on hCG day
Exclusion Criteria
  • PolyCystic Ovarian Syndrome (PCOS)
  • Endometriosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ivi Valencia

🇪🇸

Valencia, Spain

© Copyright 2025. All Rights Reserved by MedPath